Malignant Activation of a K- ras Oncogene in Lung Carcinoma But Not in Normal Tissue of the Same Patient

Detection of specific sequences among DNA fragments separated by gel electrophoresis

Southern, E. M. (1975) · Journal of Molecular Biology · doi:10.1016/s0022-2836(75)80083-0 · Cited by 32,245 · see citing works

A new method for sequencing DNA.

Maxam, A. M., & Gilbert, W. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.2.560 · Cited by 7,929 · see citing works

Mechanism of activation of a human oncogene

Tabin, C. J., Bradley, S. M., Bargmann, C. I., Weinberg, R. A., Papageorge, A. G., Scolnick, E. M., Dhar, R., Lowy, D. R., & Chang, E. H. (1982) · Nature · doi:10.1038/300143a0 · Cited by 1,393 · see citing works

A point mutation is responsible for the acquisition of transforming properties by the T24 human bladder carcinoma oncogene

Reddy, E. P., Reynolds, R. K., Santos, E., & Barbacid, M. (1982) · Nature · doi:10.1038/300149a0 · Cited by 1,391 · see citing works

Changes in size and secondary structure of the ribosomal transcription unit during vertebrate evolution

Schibler, U., Wyler, T., & Hagenbüchle, O. (1975) · Journal of Molecular Biology · doi:10.1016/0022-2836(75)90217-x · Cited by 1,195 · see citing works

The isolation and characterization of linked δ- and β-globin genes from a cloned library of human DNA

Lawn, R. M., Fritsch, E. F., Parker, R. C., Blake, G. A., & Maniatis, T. (1978) · Cell · doi:10.1016/0092-8674(78)90043-0 · Cited by 1,036 · see citing works

Human EJ bladder carcinoma oncogene is homologue of Harvey sarcoma virus ras gene

Parada, L. F., Tabin, C. J., Shih, C., & Weinberg, R. A. (1982) · Nature · doi:10.1038/297474a0 · Cited by 947 · see citing works

Transforming genes of human bladder and lung carcinoma cell lines are homologous to the ras genes of Harvey and Kirsten sarcoma viruses.

Der, C. J., Krontiris, T. G., & Cooper, G. M. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.11.3637 · Cited by 785 · see citing works

Isolation of a transforming sequence from a human bladder carcinoma cell line

Shih, C., & Weinberg, R. A. (1982) · Cell · doi:10.1016/0092-8674(82)90100-3 · Cited by 783 · see citing works

The p21 src genes of Harvey and Kirsten sarcoma viruses originate from divergent members of a family of normal vertebrate genes

Ellis, R. W., DeFeo, D., Shih, T. Y., Gonda, M. A., Young, H. A., Tsuchida, N., Lowy, D. R., & Scolnick, E. M. (1981) · Nature · doi:10.1038/292506a0 · Cited by 723 · see citing works

Activation of the T24 bladder carcinoma transforming gene is linked to a single amino acid change

Taparowsky, E. J., Suard, Y. M. L., Fasano, O., Shimizu, K., Goldfarb, M. P., & Wigler, M. H. (1982) · Nature · doi:10.1038/300762a0 · Cited by 703 · see citing works

T24 human bladder carcinoma oncogene is an activated form of the normal human homologue of BALB- and Harvey-MSV transforming genes

Santos, E., Tronick, S. R., Aaronson, S. A., Pulciani, S., & Barbacid, M. (1982) · Nature · doi:10.1038/298343a0 · Cited by 624 · see citing works

Cellular Transforming Genes

Cooper, G. M. (1982) · Science · doi:10.1126/science.6285471 · Cited by 612 · see citing works

Suppression of Malignancy by Cell Fusion

Harris, H., Miller, O. J., Klein, G., Worst, P. K. M., & Tachibana, T. (1969) · Nature · doi:10.1038/223363a0 · Cited by 604 · see citing works

Activation of Ki-ras2 gene in human colon and lung carcinomas by two different point mutations

Capon, D. J., Seeburg, P. H., McGrath, J. P., Hayflick, J. S., Edman, U., Levinson, A. D., & Goeddel, D. V. (1983) · Nature · doi:10.1038/304507a0 · Cited by 551 · see citing works

Detection of sickle cell beta S-globin allele by hybridization with synthetic oligonucleotides.

Conner, B. J., Reyes, A. A., Morin, C., Itakura, K., Teplitz, R. L., & Wallace, R. B. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.1.278 · Cited by 531 · see citing works

Structure and activation of the human N-ras gene

Taparowsky, E. J., Shimizu, K., Goldfarb, M. P., & Wigler, M. H. (1983) · Cell · doi:10.1016/0092-8674(83)90390-2 · Cited by 527 · see citing works

Isolation and preliminary characterization of a human transforming gene from T24 bladder carcinoma cells

Goldfarb, M. P., Shimizu, K., Perucho, M., & Wigler, M. H. (1982) · Nature · doi:10.1038/296404a0 · Cited by 484 · see citing works

Oncogenes in solid human tumours

Pulciani, S., Santos, E., Lauver, A. V., Long, L. K., Aaronson, S. A., & Barbacid, M. (1982) · Nature · doi:10.1038/300539a0 · Cited by 479 · see citing works

Identification of transforming gene in two human sarcoma cell lines as a new member of the ras gene family located on chromosome 1

Hall, A., Marshall, C. J., Spurr, N. K., & Weiss, R. A. (1983) · Nature · doi:10.1038/303396a0 · Cited by 438 · see citing works

Three human transforming genes are related to the viral ras oncogenes.

Shimizu, K., Goldfarb, M. P., Suard, Y. M. L., Perucho, M., Li, Y., Kamata, T., Feramisco, J. R., Stavnezer, E., Fogh, J. M., & Wigler, M. H. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.8.2112 · Cited by 389 · see citing works

Structure of the Ki-ras gene of the human lung carcinoma cell line Calu-1

Shimizu, K., Birnbaum, D., Ruley, M. A., Fasano, O., Suard, Y. M. L., Edlund, L., Taparowsky, E. J., Goldfarb, M. P., & Wigler, M. H. (1983) · Nature · doi:10.1038/304497a0 · Cited by 373 · see citing works

Acquisition of transforming properties by alternative point mutations within c-bas/has human proto-oncogene

Yuasa, Y., Srivastava, S. K., Dunn, C. Y., Rhim, J. S., Reddy, E. P., & Aaronson, S. A. (1983) · Nature · doi:10.1038/303775a0 · Cited by 366 · see citing works

Human Cell Hybrids: Analysis of Transformation and Tumorigenicity

Stanbridge, E. J., Der, C. J., Doersen, C.-J., et al. (1982) · Science · doi:10.1126/science.7053574 · Cited by 344 · see citing works

Isolation and preliminary characterization of the transforming gene of a human neuroblastoma cell line.

Shimizu, K., Goldfarb, M. P., Perucho, M., & Wigler, M. H. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.2.383 · Cited by 286 · see citing works

Nucleotide Sequence of the Oncogene Encoding the p21 Transforming Protein of Kirsten Murine Sarcoma Virus

Tsuchida, N., Ryder, T., & Ohtsubo, E. (1982) · Science · doi:10.1126/science.6287573 · Cited by 272 · see citing works

Positive cooperativity of the estrogen receptor.

Notides, A. C., Lerner, N. B., & Hamilton, D. E. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.8.4926 · Cited by 173 · see citing works

Transforming genes of human hematopoietic tumors: frequent detection of ras-related oncogenes whose activation appears to be independent of tumor phenotype.

Eva, A., Tronick, S. R., Gol, R., Pierce, J. H., & Aaronson, S. A. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.16.4926 · Cited by 169 · see citing works

Mutation Affecting the 12th Amino Acid of the c-Ha- ras Oncogene Product Occurs Infrequently in Human Cancer

Feinberg, A. P., Vogelstein, B., Droller, M. J., Baylin, S. B., & Nelkin, B. D. (1983) · Science · doi:10.1126/science.6304875 · Cited by 160 · see citing works

p21 of Kirsten murine sarcoma virus is thermolabile in a viral mutant temperature sensitive for the maintenance of transformation

Shih, T. Y., Weeks, M. O., Young, H. A., & Scolnick, E. M. (1979) · Journal of Virology · doi:10.1128/jvi.31.2.546-546.1979 · Cited by 147 · see citing works

Isolation of transforming sequences of two human lung carcinomas: structural and functional analysis of the activated c-K-ras oncogenes.

Nakano, H., Yamamoto, F., Neville, C., Evans, D., Mizuno, T., & Perucho, M. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.1.71 · Cited by 133 · see citing works

Spontaneous activation of a human proto-oncogene.

Santos, E., Reddy, E. P., Pulciani, S., et al. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.15.4679 · Cited by 114 · see citing works

Generation of BALB-MuSV and Ha-MuSV by type C virus transduction of homologous transforming genes from different species

Andersen, P. R., Devare, S. G., Tronick, S. R., et al. (1981) · Cell · doi:10.1016/0092-8674(81)90041-6 · Cited by 85 · see citing works

RAS oncogenes: the first 30 years

Malumbres, M., & Barbacid, M. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1097 · Cited by 1,902 · see citing works

Ras oncogenes: split personalities

Karnoub, A. E., & Weinberg, R. A. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2438 · Cited by 1,467 · see citing works

Ras history: The saga continues

Cox, A. D., & Der, C. J. (2010) · Small GTPases · doi:10.4161/sgtp.1.1.12178 · Cited by 706 · see citing works

Selumetinib plus docetaxel for KRAS-mutant advanced non-small-cell lung cancer: a randomised, multicentre, placebo-controlled, phase 2 study

Jänne, P. A., Shaw, A. T., Pereira, J. R., Jeannin, G., Vansteenkiste, J., Barrios, C., Franke, F. A., Grinsted, L., Zazulina, V., Smith, P., et al. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70489-8 · Cited by 655 · see citing works

Molecular Epidemiology of <i>EGFR</i> and <i>KRAS</i> Mutations in 3,026 Lung Adenocarcinomas: Higher Susceptibility of Women to Smoking-Related <i>KRAS</i> -Mutant Cancers

Dogan, S., Shen, R., Ang, D. C., Johnson, M. L., D'Angelo, S. P., Paik, P. K., Brzostowski, E. B., Riely, G. J., Kris, M. G., Zakowski, M. F., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-3265 · Cited by 639 · see citing works

KRAS Mutations in Non-Small Cell Lung Cancer

Riely, G. J., Marks, J., & Pao, W. (2009) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200809-107lc · Cited by 550 · see citing works

KRAS oncogene in non-small cell lung cancer: clinical perspectives on the treatment of an old target

Román, M., Baraibar, I., López, I., Nadal, E., Rolfo, C., Vicent, S., & Gil-Bazo, I. (2018) · Molecular Cancer · doi:10.1186/s12943-018-0789-x · Cited by 301 · see citing works

KRAS: From undruggable to a druggable Cancer Target

Uprety, D., & Adjei, A. A. (2020) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2020.102070 · Cited by 271 · see citing works

Drugging KRAS: Current perspectives and state-of-art review

Parikh, K., Banna, G., Liu, S. V., Friedlaender, A., Desai, A., Subbiah, V., & Addeo, A. (2022) · Journal of Hematology &amp; Oncology · doi:10.1186/s13045-022-01375-4 · Cited by 164 · see citing works

RAS mutations in human cancers: Roles in precision medicine

Murugan, A. K., Grieco, M., & Tsuchida, N. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.06.007 · Cited by 146 · see citing works

Current therapy of KRAS-mutant lung cancer

Ghimessy, A., Radeczky, P., Laszlo, V., Hegedus, B., Renyi-Vamos, F., Fillinger, J., Klepetko, W., Lang, C., Dome, B., & Megyesfalvi, Z. (2020) · Cancer and Metastasis Reviews · doi:10.1007/s10555-020-09903-9 · Cited by 115 · see citing works

KRAS mutations are associated with solid growth pattern and tumor-infiltrating leukocytes in lung adenocarcinoma

Rekhtman, N., Ang, D. C., Riely, G. J., Ladanyi, M., & Moreira, A. L. (2013) · Modern Pathology · doi:10.1038/modpathol.2013.74 · Cited by 117 · see citing works

Chromosomal localization of three humanras genes by in situ molecular hybridization

Popescu, N. C., Amsbaugh, S. C., DiPaolo, J. A., Tronick, S. R., Aaronson, S. A., & Swan, D. C. (1985) · Somatic Cell and Molecular Genetics · doi:10.1007/bf01534703 · Cited by 81 · see citing works

Oncogenic KRAS blockade therapy: renewed enthusiasm and persistent challenges

Tang, D., Kroemer, G., & Kang, R. (2021) · Molecular Cancer · doi:10.1186/s12943-021-01422-7 · Cited by 80 · see citing works

Pooled analysis of the prognostic and predictive value of KRAS mutation status and mutation subtype in patients with non-small cell lung cancer treated with epidermal growth factor receptor tyrosine kinase inhibitors

Zer, A., Ding, K., Lee, S. M., Goss, G. D., Seymour, L., Ellis, P. M., Hackshaw, A., Bradbury, P. A., Han, L., O’Callaghan, C. J., et al. (2016) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2015.11.010 · Cited by 56 · see citing works

Efforts to Develop KRAS Inhibitors

Holderfield, M. (2018) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a031864 · Cited by 43 · see citing works

Comparative Analysis and Isoform-Specific Therapeutic Vulnerabilities of <i>KRAS</i> Mutations in Non–Small Cell Lung Cancer

Ricciuti, B., Son, J., Okoro, J. J., Mira, A., Patrucco, E., Eum, Y., Wang, X., Paranal, R., Wang, H., Lin, M., et al. (2022) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-21-2719 · Cited by 42 · see citing works

[Study on the principles of base change in 4-fold degenerate sites of protein coding genes].

Lu, B., & Huang, P. C. (1996) · PubMed

Cytosine to Adenosine Transversion Abnormality

National Cancer Institute (2020) · Definitions · doi:10.32388/tz5d23

Transcription increases multiple spontaneous point mutations in Salmonella enterica

Hudson, R. E. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg651 · Cited by 46 · see citing works

p53 mutations in malignant gliomas.

Li, Y., Millikan, R. C., Carozza, S. E., et al. (1998) · PubMed · Cited by 21 · see citing works

[Point mutation of c-Ha-ras oncogene in oral cancers].

Liu, X. F. (1991) · PubMed · Cited by 1 · see citing works